Literature DB >> 21890287

Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.

S B Marchioro1, S Simionatto, V Galli, F R Conceição, C B Brum, A Fisch, C K Gomes, O A Dellagostin.   

Abstract

Mycoplasma hyopneumoniae is the etiological agent of swine enzootic pneumonia (EP), a chronic respiratory disease which causes significant economic losses to the swine industry worldwide. More efficient strategies for controlling this disease are necessary. In this study, we cloned17 genes coding for transmembrane proteins from M. hyopneumoniae, among which six were successfully expressed in Escherichia coli and had their immunogenic and antigenic properties evaluated. All proteins were immunogenic in mice and sera from naturally infected pigs reacted with the recombinant proteins, suggesting that they are expressed during infection. These antigens may contribute for the development of new recombinant vaccines and diagnostic tests against EP.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21890287     DOI: 10.1016/j.vetmic.2011.08.001

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a cocktail vaccine enhance the immune response of mice.

Authors:  Vanessa Galli; Simone Simionatto; Silvana Beutinger Marchioro; Gustavo Henrique Ferrero Klabunde; Fabricio Rochedo Conceição; Odir Antônio Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2013-06-26

2.  Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2.

Authors:  Yu Tao; Rui Yang; Jianhong Shu; Wenqian Zheng; Jian Chen; Yuehong Wu; Yulong He
Journal:  BMC Vet Res       Date:  2020-09-16       Impact factor: 2.741

3.  Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae by a Baculovirus Expression System.

Authors:  Yu Tao; Gaojian Li; Wenqian Zheng; Jianhong Shu; Jian Chen; Fang Yang; Yuehong Wu; Yulong He
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

4.  Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.

Authors:  Yongheng Wang; Jialu Wang; Mengyun Zhou; Peng Liu; En Zhang; Yuchen Li; Jian Lin; Zhixin Feng; Qian Yang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.